Stay updated on Inotuzumab Ozogamicin in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inotuzumab Ozogamicin in B-ALL Clinical Trial page

  1. Check
    9 days ago
    Change Detected
    Summary
    The history page shows Revision: v3.3.2 added, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:33:18.000Z thumbnail image
  2. Check
    16 days ago
    Change Detected
    Summary
    Revision history updated: v3.3.1 added and v3.2.0 removed; core trial content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:34:05.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page, eliminating the banner about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:15:32.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The old and new screenshots show only visual/UI updates with no modifications to the study data or record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:49:29.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The latest history entry for NCT03959085 adds Contacts/Locations and Study Status (version 48 dated 2025-10-24). A prior entry from 2025-09-18 has been removed.
    Difference
    0.3%
    Check dated 2025-10-26T20:25:41.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    9%
    Check dated 2025-10-05T07:26:25.000Z thumbnail image

Stay in the know with updates to Inotuzumab Ozogamicin in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.